The post COVID-19 healthcare landscape and the use of long-acting injectable antipsychotics for individuals with schizophrenia and bipolar I disorder: the importance of an integrated collaborative-care approach

BACKGROUND: Long-acting injectable antipsychotics (LAIs) are an essential maintenance treatment option for individuals with schizophrenia or bipolar I disorder (BP-I). This report summarizes a roundtable discussion on the impact of COVID-19 on the mental healthcare landscape and use of LAIs for indi...

Descripción completa

Detalles Bibliográficos
Autores principales: Correll, Christoph U., Chepke, Craig, Gionfriddo, Paul, Parks, Joe, Foxworth, Phyllis, Basu, Anirban, Brister, Teri S., Brown, Dawn, Clarke, Christopher, Hassoun, Youssef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745550/
https://www.ncbi.nlm.nih.gov/pubmed/35012512
http://dx.doi.org/10.1186/s12888-022-03685-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745550/
https://www.ncbi.nlm.nih.gov/pubmed/35012512
http://dx.doi.org/10.1186/s12888-022-03685-w

Ejemplares similares